Abstract
Our studiesin vitro demonstrate that neutrophil mediated injury of isolated cardiac myocytes requires the presence of ICAM-1 on the surface of the myocyte and CD11b/CD18 activation on the neutrophil. In post-ischemic cardiac lymph, there is rapid appearance of C5a activity during the first hours of reperfusion. Interleukin-6 activity is present throughout the first 72 h of reperfusion and is sufficient to induce ICAM-1 on the surface of the cardiac myocyte.In situ hybridization studies suggest that ICAM-1 mRNA is found in viable myocardial cells on the edge of the myocardial infarction within 1 h of reperfusion. ICAM-1 protein expression on cardiac myocytes is seen after 6 h of reperfusion, and increases thereafter. Non-ischemic tissue demonstrates no early induction of ICAM-1 mRNA or ICAM-1 protein on myocardial cells. In our most recent experiments, we have determined that reperfusion is an absolute requirement for the early induction of myocardial ICAM-1 mRNA in previously ischemic myocardial cells. To further assess this, we have cloned and sequenced a canine interleukin-6 (IL-6) cDNA. The data suggest that early induction of IL-6 mRNA is also reperfusion dependent as it could be demonstrated in the same ischemic and reperfused segments in which ICAM-1 mRNA was found. Peak expression of IL-6 mRNA occurred much earlier than that for ICAM-1 mRNA. Similar experiments were then performed with a molecular probe for interleukin-8 (IL-8). This chemokine is a potent neutrophil stimulant and has a higher degree of specificity for neutrophils than classic chemoattractants such as C5a. The results suggest a similar pattern of induction that occurs within the first hour and is markedly, increased by reperfusion. The relationship of reperfusion to ICAM-1 and cytokine induction is discussed.
Similar content being viewed by others
References
Entman ML, Kukielka GL, Ballantyne CM, Smith CW: The role of leukocytes in ischemic heart disease. In: C. Chapman (ed.). Handbook of immunopharmacology. Academic Press Limited Harcourt Brace Hovanovich, London, 1993, pp 55–74
Dreyer WJ, Michael LH, West MS, Smith CW, Rothlein R, Rossen RD, Anderson DC, Entman ML: Neutrophil accumulation in ischemic canine myocardium: Insights into the time course, distribution, and mechanism of localization during early reperfusion. Circulation 84: 400–411, 1991
Rossen RD, Swain JL, Michael LH, Weakley S, Giannini E, Entman ML: Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle: A possible initiator of an extra mycardial mechanism of ischemic injury. Circ Res 57: 119–130, 1985
Rossen RD, Michael LH, Kagiyama A, Savage HE, Hanson G, Reisbery JN, Moake JN, Kim SH, Weakly S, Giannini E, Entman ML: Mechanism of complement activation following coronary artery occlusion: Evidence that myocardial ischemia causes release of constituents of myocardial subcellular origin which complex with the first component of complement. Circ Res 62: 572–584, 1988
Pinckard RN, Olson MS, Giclas PC, Terry R, Boyer JT, O'Rourke RA: Consumption of classical complement components by heart subcellular membranesin vitro and in patients after acute myocardial infarction. J Clin Invest 56: 740–750, 1975
Hill JH, Ward PA: The phlogistic role of C3 leukotactic fragment in myocardial infarcts of rats. J Exp Med 133: 885–900, 1971
Dreyer WJ, Smith CW, Michael LH, Rossen RD, Hughes BJ, Entman ML, Anderson DC: Canine neutrophil activation by cardiac lymph obtained during reperfusion of ischemic myocardium. Circ Res 65: 1751–1762, 1989
Crawford MH, Grover FL, Kolb WP, McMahan CA, O'Rourke RA, McManus LM, Pinckard RN: Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. Circulation 78: 1449–1458, 1988
Weisman HF, Barton T Leppo MK, Marsh HC Jr, Carson GR, Concino MF, Boyle MP, Roux KH, Weisfeldt ML, Fearon DT: Soluble human complement receptor type 1:In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249: 146–151, 1990
Hughes BJ, Hollers JC, Crockett-Torabi E, Smith CW: Recruitment of CD11b/CD18 to the neutrophil surface and adherence-dependent cell locomotion. J Clin Invest 90: 1687–1696, 1992
Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA, Lucchesi BR: Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 67: 1016–1023, 1983
Mullane KM, Read N, Salmon JA, Moncada S: Role of leukocytes in acute myocardial infarction in anesthetized dogs. Relationship to myocardial salvage by anti-inflammatory drugs. J Pharmacol Exp Ther 228: 510–522, 1984
Maroko PR, Carpenter CD, Chiariello M, Fishbein, MC, Radvany P, Knostman JD, Hale SL: Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. J Clin Invest 61: 661–670, 1978
Simpson PJ, Todd III, Fantone JC, Mickelson JK, Griffin JD, Lucchesi BR: Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mol, anti-CD11b) that inhibits leukocyte adhesion. J Clin Invest 81: 624–629, 1988
Williams FM, Collins PD, Nourshargh S, Williams TJ: Suppression of 1ll In-neutrophil accumulation in rabbit myocardium by MoA ischemic injury. J Mol Cell Cardio 20: S331988
Seewaldt-Becker E, Rothlein R, Dammgen JW: CDw 18 dependent adhesion of leukocytes to endothelium and its relevance for cardiac reperfusion. In: T.A. Springer, D.C. Anderson A.S. Rosenthal and R. Rothlein (eds). Leukocyte Adhesion Molecules: Structure, Function and Regulation. Springer-Verlag, New York, New York, 1989, pp 138–148
Simpson PJ, Todd III, Mickelson JK, Fantone JC, Gallagher KP, Lee KA, Tamura Y, Cronin M, Lucchesi BR: Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alter leukocyte function. Circulation 81: 226–237, 1990
Tanaka M, Brooks SE, Fitzharris GP, Stoler RC, Jennings RB, Reimer KA. Effect of the IB4 anti-CD18 antibody on myocardial PMN accumulation and infarct size in dogs. FASEB J 4: A10201990
Ma XL, Tsao PS, Lefer AM: Antibody to CD18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. J Clin Invest 88: 1237–1243, 1991
Lefer DJ, Suresh ML, Shandelya ML, Serrano CV, Becker LC, Kuppusamy P, Zweier JL: Cardioprotective actions, of a monoclonal antibody against CD-18 in myocardial ischemia-reperfusion injury. Circulation: 88: 1779–1787, 1993
Michael LH, Hunt JR, Weilbaecher D, Perryman MB, Roberts R, Lewis RM, Entman ML: Creatine kinase and phosphorylase in cardiac lymph: Coronary occlusion and reperfusion. Am J Physiol 248: H350-H359, 1985
Rossen RD: Complement activation in cardiac disease. In: C. Page, M.J. Curtis (eds). The handbook of immunopharmacology. Academic Press Limited, United Kingdom, 1993, pp 75–86
Entman ML, Youker KA, Shappell SB, Siegel C, Rothlein R, Dreyer WJ, Schmalstieg FC, Smith CW: Neutrophil adherence to isolated adult canine myocytes: Evidence for a CD18-dependent mechanism. J Clin Invest 85: 1497–1506, 1990
Smith CW, Entman ML, Lane CL, Beaudet AL, Ty TI, Youker KA, Hawkins HK, Anderson DC: Adherence of neutrophils to canine cardiac myocytesin vitro is dependent on intercellular adhesion molecule-1. J Clin Invest 88: 1216–1223, 1991
Entman ML, Youker KA, Shoji T, Kukielka GL, Shappell SB, Taylor AA, Smith CW: Neutrophil induced oxidative injury of cardiac myocytes: A compartmented system requiring CD11b/CD18-ICAM-1 adherence. J Clin Invest 90: 1335–1345, 1992
Youker KA, Smith CW, Anderson DC, Miller D, Michael LH, Rossen RD, Entman ML: Neutrophil adherence to isolated adult cardiac myocytes: Induction by cardiac lymph collected during ischemia and reperfusion. J Clin Invest 89: 602–609, 1992
Kukielka GL, Hawkins HK, Michael LH, Manning AM, Lane CL, Entman ML, Smith CW, Anderson DC: Regulation of intercellular adhesion molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium. J Clin Invest 92: 1504–1516, 1993
Baggiolini M, Dewald B, Walz A: Interleukin-8 and related chemotactic cytokines. In: J.I. Gallin, I.M. Goldstein and R. Snyderman (eds). Inflammation: Basic principles and clinical correlates. Raven Limited, New York, 1992, pp 247–263
Baggiolini M, Walz A, Kunkel SL: Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84: 1045–1049, 1989
Miller MD, Krangel MS: Biology and biochemistry of the chemokines: A family of chemotactic and inflammatory cytokines. Crit Rev Immunol 12: 17–46, 1992
Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76,: 301–314, 1994
Youker KA, Hawkins HK, Kukielka GL, Perrard JL, Michael LH, Ballantyne CM, Smith CW, Entman ML: Molecular evidence for induction of ICAM-1 in the viable border zone associated with ischemia-reperfusion onjury of the dog heart. Circulation 1994, (in press)
Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159, 1987
Kukielka GL, Youker KA, Hawkins HK, Perrard JL, Michael LH, Ballantyne CM, Smith CW, Entman ML. Regulation of ICAM-1 and IL-6 in myocardial ischemia: Effect of reperfusion. Ann N Y Acad Sci 1994, (in press)
Matsushima K, Morishita K, Yoshimura T, Lavu S, Kobayashi Y, Lew W, Apella E, Kung HF, Leonard EJ, Oppenheim JJ: Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med 167: 1883–1893, 1988
Goodman RB, Foster DC, Mathewes SL, Osborn SG, Kuijper JL, Forstrom JW, Martin TR: Molecular cloning of porcine alveolar macrophage-derived neutrophil chemotactic factors I and II: Identification of poreine IL-8 and another intercrine-α protein. Biochemistry 31: 10483–10490, 1992
Lie JT, Holley KE, Titus JL: Fuchsinorrhagia—A new histochemical indication of inapparent early myocardial ischemia. Lab Med 3: 37–40, 1972
Mallory GK, White PD, Salcedo-Salgar J: The speed of healing of myocardial infarction. A study of the pathologic anatomy in seventy-two cases. Am Heart J 18: 647–671, 1939
Fishbein MC, Maclean D, Maroko PR: The histopathologic evolution of myocardial infarction. Chest 73: 843–849, 1978
Miller D, Krangel MS: Biology and biochemistry of the chemokines: A family of chemotactic and inflammatory cytokines. Crit Rev Immunol 12:17–46, 1992
Marucha PT, Zeff RA, Kreutzer DL: Cytokine regulation of IL-Ibeta gene expression in the human polymorphonuclear leukocyte. J Immunol 145: 2932–2937, 1990
Marucha PT, Zeff RA, Kreutzer DL: Cytoline-induced IL-1B gene expression in the human polymorphonuclear leukocyte: Transcriptional and post-transcriptional regulation by tumor necrosis factor and IL-1. J Immunol 147: 2603–2608, 1991
Ember JA, Sanderson SD, Hugli TE, Morgan EL: Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. Am J Pathol 144: 393–403, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kukielka, G.L., Youker, K.A., Michael, L.H. et al. Role of early reperfusion in the induction of adhesion molecules and cytokines in previously ischemic myocardium. Mol Cell Biochem 147, 5–12 (1995). https://doi.org/10.1007/BF00944777
Issue Date:
DOI: https://doi.org/10.1007/BF00944777